Quantcast

Karen Hughes Joins Omnia Biologics

April 8, 2014

ROCKVILLE, Md., April 8, 2014 /PRNewswire/ — Biologics development and manufacturing services provider Omnia Biologics, Inc. (Omnia) (Rockville, MD) today announced that Karen Hughes has joined the Omnia team as Senior Director of Quality Assurance and Quality Control.

Over the course of her nearly 23 year career in quality assurance, she has held quality positions of increasing responsibility in the manufacturing of pioneering pharmaceutical and biologic products. Karen worked for some of the regions premier drug development organizations including Chesapeake Biological Laboratories, Guilford Pharmaceuticals and most recently Emergent BioSolutions where she was Senior Director of Quality Assurance for both product development as well as manufacturing operations.

“I often tell people that there is no more important position in our organization than the person who heads our quality group. Karen brings a wealth of knowledge in the development of biologics from pre-clinical to clinical products.” Dr. Dale VanderPutten, CEO, Omnia Biologics, Inc. commented. “She is a fantastic resource for our clients to effectively move their products forward in the clinic and we are overjoyed to have her on our team at Omnia.”

Mrs. Hughes has been certified as a Quality Auditor by the American Society for Quality. She has served as an instructor on cGMPs at the University of Maryland Biotechnology Institute and as a speaker at the Maryland Center for Quality and Productivity ISO 9000 Consortium.

About Omnia Biologics: (www.omniabiologics.com)
Omnia offers translational medicine services in the areas of process development, assay development, GMP manufacture, and fill-finish for preclinical and clinical programs for therapeutics that do not have effective or known manufacturing protocols. These include vaccines, autologous therapeutics, new gene therapeutic platforms, and stem cell technologies. The company seeks and has established relationships with both biopharmaceutical companies and academic investigators throughout the world.

CONTACT:
Sami Cardak Omnia Biologics, Inc. 12111 Parklawn Drive, Rockville, Maryland, 20852, USA, E-mail: info@omniabio.com, Tel: 301-984-5928, Fax 301-984-2515.

SOURCE Omnia Biologics, Inc.


Source: PR Newswire



comments powered by Disqus